Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Intangibles (2019 - 2023)

Historic Intangibles for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to $12.4 million.

  • ADC Therapeutics' Intangibles fell 1534.46% to $12.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $12.4 million, marking a year-over-year decrease of 1534.46%. This contributed to the annual value of $14.4 million for FY2022, which is 10562816.96% up from last year.
  • Latest data reveals that ADC Therapeutics reported Intangibles of $12.4 million as of Q3 2023, which was down 1534.46% from $13.5 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Intangibles ranged from a high of $14.6 million in Q3 2022 and a low of $8825.0 during Q2 2020
  • Moreover, its 5-year median value for Intangibles was $12.8 million (2021), whereas its average is $10.9 million.
  • Its Intangibles has fluctuated over the past 5 years, first surged by 13599065.16% in 2021, then tumbled by 1534.46% in 2023.
  • Quarter analysis of 5 years shows ADC Therapeutics' Intangibles stood at $9.4 million in 2019, then plummeted by 99.9% to $9814.0 in 2020, then surged by 112840.43% to $11.1 million in 2021, then grew by 29.56% to $14.4 million in 2022, then decreased by 13.94% to $12.4 million in 2023.
  • Its Intangibles was $12.4 million in Q3 2023, compared to $13.5 million in Q2 2023 and $13.6 million in Q1 2023.